PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 72.60
-0.50 (-0.68%)
At close: Dec 5, 2025
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 10.43 billion as of December 5, 2025. Its market cap has decreased by -30.19% in one year.
Market Cap
10.43B
Enterprise Value
5.84B
Revenue
2.51B
Ranking
n/a
PE Ratio
6.24
Stock Price
72.60
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 10.43B, an increase of 93.93%. That is a compound annual growth rate of 4.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 10.43B | -19.60% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | 8.43B | -15.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.37B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.68B |
| Center Laboratories | 27.88B |